Amoxyheal CV 625

Amoxyheal CV 625 is intended for susceptible bacterial infections. Exact authorized indications vary by country and product label.

• India: Healing Pharma's product information lists respiratory and ENT infections, urinary infections, skin and soft-tissue infections, osteomyelitis and dental infections among uses for the 625 mg combination.

• United States: Current FDA labeling for 500/125 mg amoxicillin/clavulanate tablets covers lower respiratory tract infections, acute bacterial otitis media, sinusitis, skin/skin-structure infections and urinary tract infections.

• United Kingdom: NHS guidance describes co-amoxiclav use for selected ear and sinus infections, respiratory infections, skin infections and dental infections.

• It does not treat viral illnesses such as colds or influenza, and unnecessary antibiotic use contributes to resistance.

The correct regimen depends on the infection, severity, age, body weight, kidney function and the exact formulation.

For the 500 mg/125 mg strength, current U.S. labeling provides adult reference regimens of 500/125 mg every 12 hours for less severe infections or 500/125 mg every 8 hours for more severe infections and respiratory infections. UK practice commonly uses 625 mg three times daily for selected adult indications. These are label/guideline examples, not an individualized prescription.

Renal impairment may require adjustment, and the 875/125 mg formulation has additional renal restrictions. Do not increase, reduce or repeat doses without medical advice.

• Take the tablet exactly as prescribed.

• Take it at the start of a meal to improve clavulanate absorption and reduce gastrointestinal intolerance.

• Swallow the tablet with water unless the supplied leaflet gives different instructions.

• Space doses evenly when multiple daily doses are prescribed.

• Complete the prescribed course unless the clinician changes the treatment.

If a dose is missed, follow the product leaflet or prescriber's instructions; do not double the next dose.

The most frequently reported effects with amoxicillin/clavulanate include:

• Diarrhea or loose stools

• Nausea or vomiting

• Abdominal discomfort or indigestion

• Skin rash or hives

• Vaginal thrush or other mucocutaneous candidiasis

Taking the medicine with food may help reduce stomach upset. Persistent or severe diarrhea can sometimes indicate Clostridioides difficile-associated disease and requires medical assessment, particularly if it occurs during treatment or after the course has finished.

Medicine or condition	Why it matters
Penicillin or serious beta-lactam allergy	May cause severe hypersensitivity, including anaphylaxis
Previous cholestatic jaundice/liver dysfunction from this combination	Further treatment may be inappropriate
Warfarin/oral anticoagulants	Co-amoxiclav may affect coagulation; monitoring may be needed
Allopurinol	May increase the likelihood of rash
Probenecid	Co-administration is generally not recommended
Methotrexate	May increase toxicity risk; medical review is important
Kidney disease	Dose selection may need adjustment

Tell the prescriber about allergies, previous antibiotic-related liver problems, kidney or liver disease, pregnancy or breastfeeding, and all medicines and supplements being taken.

Amoxyheal CV 625 should be used only when a bacterial infection is suspected or confirmed and the combination is considered appropriate. It should not be used for viral infections such as colds or influenza. Using antibiotics unnecessarily can promote antimicrobial resistance.

Do not use this medicine if there has previously been a serious allergic reaction to penicillins or other beta-lactam antibiotics. Serious reactions can include anaphylaxis, severe skin reactions and swelling of the face or throat. Seek urgent medical attention for breathing difficulty, facial or throat swelling, blistering or peeling skin, or a rapidly spreading rash.

Amoxicillin/clavulanate can also cause liver injury or cholestatic jaundice. People with previous liver problems caused by this combination require particular caution. Severe or persistent watery or bloody diarrhea may indicate C. difficile infection and requires prompt assessment.

People with kidney impairment may require a different dosing schedule. Patients with mononucleosis can develop a prominent rash after amoxicillin-containing treatment.

During pregnancy, co-amoxiclav can generally be used when a clinician considers it necessary; breastfeeding is also generally compatible, but professional advice is appropriate for individual circumstances.

This information is for general education and does not replace advice from a doctor, pharmacist or qualified healthcare professional.